CVRX

CVRx, Inc.

Export transactions ↓

Tapewire entity: 6920
SEC CIK: 0001235912
Parsed reports: 179

Last 12 months

Inside the activity.

3 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Monthly counts

Month	Purchases	Sales
Nov 2025	0	8
Dec 2025	0	0
Jan 2026	0	0
Feb 2026	2	0
Mar 2026	0	5
Apr 2026	0	0
May 2026	0	0
Jun 2026	0	0
Jul 2026	0	0
Aug 2026	1	1
Sep 2026	0	0
Oct 2026	0	0

Latest available

Insider transactions

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Owner / reported role	Activity / security	Shares / units	Reported price	Reported value	Details
December 28, 2023 Filed Jan 2, 2024 21:57 UTC	SLATTERY JOSEPH PDirector	Exercise / conversionCommon Stock	1,456	$0.24	$345.07	Disclosure SEC source: 0001415889-24-000059 · form4-01022024_090117.xml · nonDerivative · entry 2 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 28, 2023 Filed Jan 2, 2024 21:57 UTC	SLATTERY JOSEPH PDirector	Exercise / conversionCommon Stock	224	$0.24	$53.09	Disclosure SEC source: 0001415889-24-000059 · form4-01022024_090117.xml · nonDerivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:40 UTC	Behbahani AliDirector	Exercise / conversionStock Option (right to buy) · Derivative	316	$0.00 Strike: $0.24	$0.00	Disclosure SEC source: 0001209191-23-058968 · doc4.xml · derivative · entry 2 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 316 shares Expires 2023-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:40 UTC	Behbahani AliDirector	Exercise / conversionCommon Stock	316	$0.24	$74.89	Disclosure SEC source: 0001209191-23-058968 · doc4.xml · nonDerivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 16, 2023 Filed Oct 18, 2023 16:51 UTC	Galle LizVP OF GLOBAL CLINICAL RESEARCH	Exercise / conversionStock Option (right to buy) · Derivative	778	$0.00 Strike: $0.24	$0.00	Disclosure SEC source: 0001415889-23-014406 · form4-10182023_081024.xml · derivative · entry 2 Galle Liz · CIK 0001869353 · VP OF GLOBAL CLINICAL RESEARCH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 778 shares Expires 2023-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document
October 16, 2023 Filed Oct 18, 2023 16:51 UTC	Galle LizVP OF GLOBAL CLINICAL RESEARCH	Exercise / conversionCommon Stock	778	$0.24	$184.39	Disclosure SEC source: 0001415889-23-014406 · form4-10182023_081024.xml · nonDerivative · entry 1 Galle Liz · CIK 0001869353 · VP OF GLOBAL CLINICAL RESEARCH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 18, 2023 Filed Sep 20, 2023 16:04 UTC	OASHEIM JAREDCHIEF FINANCIAL OFFICER	Exercise / conversionStock Option (right to buy) · Derivative	5,335	$0.00 Strike: $3.96	$0.00	Disclosure SEC source: 0001415889-23-013458 · form4-09202023_080953.xml · derivative · entry 4 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,732 Underlying: Common Stock · 5,335 shares Expires 2029-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares on each month thereafter. Read SEC document
September 18, 2023 Filed Sep 20, 2023 16:04 UTC	OASHEIM JAREDCHIEF FINANCIAL OFFICER	Exercise / conversionStock Option (right to buy) · Derivative	527	$0.00 Strike: $0.24	$0.00	Disclosure SEC source: 0001415889-23-013458 · form4-09202023_080953.xml · derivative · entry 3 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 527 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document
September 18, 2023 Filed Sep 20, 2023 16:04 UTC	OASHEIM JAREDCHIEF FINANCIAL OFFICER	Exercise / conversionCommon Stock	5,335	$3.96	$21,099.93	Disclosure SEC source: 0001415889-23-013458 · form4-09202023_080953.xml · nonDerivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 18, 2023 Filed Sep 20, 2023 16:04 UTC	OASHEIM JAREDCHIEF FINANCIAL OFFICER	Exercise / conversionCommon Stock	527	$0.24	$124.90	Disclosure SEC source: 0001415889-23-013458 · form4-09202023_080953.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 15, 2023 Filed Sep 18, 2023 13:25 UTC	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherCommon Stock	3,495,575	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-019200 · doc4.xml · nonDerivative · entry 1 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · balance_after: The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · ownership.direct: The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	1,264	Not disclosed Strike: $5.14	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 16 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,264 shares Expires 2031-01-04 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F5 · derivative.exercise_date: Vests as to 1/48th of the shares each month commencing January 11, 2021. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	758	Not disclosed Strike: $3.96	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 15 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 758 shares Expires 2029-12-05 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F4 · derivative.exercise_date: Vests as to 1/48th of the shares each month commencing January 6, 2020. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	142	Not disclosed Strike: $1.19	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 14 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 142 shares Expires 2028-11-28 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	758	Not disclosed Strike: $1.19	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 13 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 758 shares Expires 2028-11-28 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	300	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 12 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2028-02-15 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	758	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 11 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 758 shares Expires 2028-02-15 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	489	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 10 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 489 shares Expires 2027-02-01 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	758	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 9 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 758 shares Expires 2027-02-01 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	85	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 8 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85 shares Expires 2025-11-09 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	23	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 7 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23 shares Expires 2025-08-06 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	71	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 6 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71 shares Expires 2025-08-06 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	118	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 5 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 118 shares Expires 2025-08-06 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	165	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 4 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165 shares Expires 2025-08-06 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	189	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 3 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 189 shares Expires 2025-08-06 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	158	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 2 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 158 shares Expires 2024-11-18 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
September 15, 2023 Filed Feb 2, 2024 22:47 UTC Amendment	Johnson & Johnson Innovation - JJDC, Inc.10% owner	OtherStock Option (Right to Buy) · Derivative	237	Not disclosed Strike: $0.24	Not disclosed	Disclosure SEC source: 0000950170-24-010710 · ownership.xml · derivative · entry 1 Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 237 shares Expires 2023-12-14 F1 · security: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · security: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · kind: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · kind: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F1 · price: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · price: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. F3 · derivative.exercise_date: Fully vested. F1 · ownership.direct: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law, F2 · ownership.direct: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein. Read SEC document
August 03, 2023 Filed Aug 7, 2023 16:58 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	SaleCommon Stock	628	$18.55	$11,652.48	Disclosure SEC source: 0001415889-23-011901 · form4-08072023_080826.xml · nonDerivative · entry 1 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document
August 02, 2023 Filed Aug 2, 2023 18:29 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	GiftCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0001415889-23-011778 · form4-08022023_100851.xml · nonDerivative · entry 3 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628 Read SEC document
July 31, 2023 Filed Aug 2, 2023 18:29 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	Exercise / conversionStock Option (right to buy) · Derivative	3,750	$5.14 Strike: $5.14	$19,278.75	Disclosure SEC source: 0001415889-23-011778 · form4-08022023_100851.xml · derivative · entry 4 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,806 Underlying: Common Stock · 3,750 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vests as to 25% of the shares on January 4, 2022 and vests as to 1/48th of the shares each month thereafter. Read SEC document
July 31, 2023 Filed Aug 2, 2023 18:29 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	SaleCommon Stock	1,122	$17.49	$19,629.17	Disclosure SEC source: 0001415889-23-011778 · form4-08022023_100851.xml · nonDerivative · entry 2 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,628 F1 · price: Reflects the weighted average price of 3,750 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on July 31, 2023 with sale prices ranging from $17.47 to $17.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document
July 31, 2023 Filed Aug 2, 2023 18:29 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	Exercise / conversionCommon Stock	3,750	$5.14	$19,278.75	Disclosure SEC source: 0001415889-23-011778 · form4-08022023_100851.xml · nonDerivative · entry 1 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:12 UTC	SHADAN MARTHADirector	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001415889-23-009358 · form4-06072023_080633.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
June 05, 2023 Filed Jun 7, 2023 16:13 UTC	Hykes KevinDirector	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001415889-23-009359 · form4-06072023_080623.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:13 UTC	SLATTERY JOSEPH PDirector	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001415889-23-009360 · form4-06072023_080648.xml · derivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
June 05, 2023 Filed Jun 7, 2023 22:54 UTC	Behbahani AliDirector	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001209191-23-035223 · doc4.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:14 UTC	Jain Mudit K.Director	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001415889-23-009361 · form4-06072023_080615.xml · derivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:12 UTC	Nielsen Kirk G.Director	GrantStock Option (right to buy) · Derivative	12,012	$0.00 Strike: $12.33	$0.00	Disclosure SEC source: 0001415889-23-009357 · form4-06072023_080657.xml · derivative · entry 1 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document
May 16, 2023 Filed May 18, 2023 20:51 UTC	Palmer Craig E.SVP, U.S. SALES	Exercise / conversionStock Option (right to buy) · Derivative	295	$0.00 Strike: $0.24	$0.00	Disclosure SEC source: 0001415889-23-008284 · form4-05182023_080549.xml · derivative · entry 2 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 295 shares Expires 2023-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document
May 16, 2023 Filed May 18, 2023 20:51 UTC	Palmer Craig E.SVP, U.S. SALES	Exercise / conversionCommon Stock	295	$0.24	$69.92	Disclosure SEC source: 0001415889-23-008284 · form4-05182023_080549.xml · nonDerivative · entry 1 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 18, 2023 Filed Jan 20, 2023 19:10 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	GrantStock Option (right to buy) · Derivative	45,000	$0.00 Strike: $15.22	$0.00	Disclosure SEC source: 0001415889-23-001284 · form4-01212023_120102.xml · derivative · entry 1 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document
January 18, 2023 Filed Jan 20, 2023 19:12 UTC	OASHEIM JAREDCHIEF FINANCIAL OFFICER	GrantStock Option (right to buy) · Derivative	70,000	$0.00 Strike: $15.22	$0.00	Disclosure SEC source: 0001415889-23-001285 · form4-01212023_120148.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document
January 18, 2023 Filed Jan 20, 2023 19:14 UTC	Galle LizVP OF GLOBAL CLINICAL RESEARCH	GrantStock Option (right to buy) · Derivative	26,000	$0.00 Strike: $15.22	$0.00	Disclosure SEC source: 0001415889-23-001287 · form4-01212023_120100.xml · derivative · entry 1 Galle Liz · CIK 0001869353 · VP OF GLOBAL CLINICAL RESEARCH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document
January 18, 2023 Filed Jan 21, 2023 00:13 UTC	Palmer Craig E.SVP, U.S. SALES	GrantStock Option (right to buy) · Derivative	40,000	$0.00 Strike: $15.22	$0.00	Disclosure SEC source: 0001415889-23-001286 · form4-01212023_120125.xml · derivative · entry 1 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document
January 18, 2023 Filed Jan 21, 2023 00:09 UTC	Yared NadimDirector · CHIEF EXECUTIVE OFFICER	GrantStock Option (right to buy) · Derivative	200,000	$0.00 Strike: $15.22	$0.00	Disclosure SEC source: 0001415889-23-001283 · form4-01212023_120120.xml · derivative · entry 1 Yared Nadim · CIK 0001554977 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document
January 11, 2023 Filed Jan 13, 2023 21:13 UTC	Yared NadimDirector · CHIEF EXECUTIVE OFFICER	GiftCommon Stock	7,080	$0.00	$0.00	Disclosure SEC source: 0001415889-23-000964 · form4-01132023_090127.xml · nonDerivative · entry 1 Yared Nadim · CIK 0001554977 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,255 Read SEC document
December 21, 2022 Filed Dec 23, 2022 16:02 UTC	Hykes KevinDirector	GrantStock Option (right to buy) · Derivative	21,776	$0.00 Strike: $15.78	$0.00	Disclosure SEC source: 0001415889-22-012964 · form4-12232022_091257.xml · derivative · entry 2 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,776 Underlying: Common Stock · 21,776 shares Expires 2032-12-21 F2 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant. Read SEC document
December 21, 2022 Filed Dec 23, 2022 16:02 UTC	Hykes KevinDirector	GrantStock Option (right to buy) · Derivative	5,246	$0.00 Strike: $15.78	$0.00	Disclosure SEC source: 0001415889-22-012964 · form4-12232022_091257.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,246 Underlying: Common Stock · 5,246 shares Expires 2032-12-21 F1 · derivative.exercise_date: Vests on the earlier of December 21, 2023 or the Issuer's 2023 annual meeting of stockholders. Read SEC document
November 30, 2022 Filed Nov 30, 2022 17:55 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	GiftCommon Stock	4,400	$0.00	$0.00	Disclosure SEC source: 0001415889-22-011857 · form4-11302022_101152.xml · nonDerivative · entry 4 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: Represents a gift of securities by the reporting person to his adult children who do not share the reporting person's household. Read SEC document
November 28, 2022 Filed Nov 30, 2022 17:55 UTC	VERRASTRO PAULCHIEF MKTG & STRAT OFFICER	Exercise / conversionStock Option (right to buy) · Derivative	9,000	$0.00 Strike: $5.14	$0.00	Disclosure SEC source: 0001415889-22-011857 · form4-11302022_101152.xml · derivative · entry 5 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,556 Underlying: Common Stock · 9,000 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vests as to 25% of the shares on January 4, 2022 and vests as to 1/48th of the shares each month thereafter. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.